An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life

Scandinavian Journal of Rheumatology

Volumn 41, Issue 5, 2012, Pages 383-390

  Pettersson, S ^a,b   Lovgren M ^c,d   Eriksson, L E ^b   Moberg, C ^b   Svenungsson, E ^a,b   Gunnarsson, I ^a,b   Henriksson, E Welin ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c DALARNA UNIVERSITY   (Sweden)

^d Stockholms Sjukhem Foundation   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID;

ABDOMINAL DISCOMFORT; ADULT; AGED; ALLERGY; ANXIETY; ARTHRITIS; ARTICLE; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; COGNITIVE DISTRESS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DISCOID RASH; DISEASE ACTIVITY; DISEASE DURATION; DISTRESS SYNDROME; EMOTIONAL STRESS; EYE DISEASE; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HAIR DISEASE; HEART DISEASE; HEMATOLOGIC DISEASE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFECTION; KIDNEY DYSFUNCTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALAR RASH; MALE; MEASUREMENT; MOUTH DISEASE; MOUTH ULCER; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL DISTRESS; NAIL DISEASE; NEPHRITIS; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PAIN; PERICARDITIS; PHOTOSENSITIVITY DISORDER; PHYSICAL CAPACITY; PLEURISY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RASH; RATING SCALE; REPRODUCTION; SELF REPORT; SHORT FORM 36; SKIN DISEASE; SLEEP DISORDER; STEROID THERAPY; SWELLING; SYMPTOMATOLOGY; SYSTEMIC LUPUS ACTIVITY MEASURE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; DIAGNOSTIC SELF EVALUATION; FATIGUE; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84867275923     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2012.677857     Document Type: Article

References (42)

1. Swaak AJG. Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology 1999;10:953-8.
2. Tench CM, McCurdie I, White PD, D'Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) 2000;11:1249-54.
3. McElhone K, Abbott J, Gray J, Williams A, Teh LS. Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study. Lupus 2010;14:1640-7.
4. Stamm TA, Bauernfeind B, Coenen M, Feierl E, Mathis M, Stucki G, et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum 2007;7:1287-95.
5. Haq I, Isenberg DA. How does one assess and monitor patients with systemic lupus erythematosus in daily clinical practice? Best Pract Res Clin Rheumatol 2002;2:181-94.
6. Kirwan JR, Newman S, Tugwell PS, Wells GA. Patient perspective on outcomes in rheumatology -A position paper for OMERACT 9. J Rheumatol 2009;9:2067-70.
7. Grootscholten C, Ligtenberg G, Derksen RH, Schreurs KM, de Glas-Vos JW, Hagen EC, et al. Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist. Qual Life Res 2003;6:635-44.
8. Freire EA, Guimaraes E, Maia I, Ciconelli RM. Systemic lupus erythematosus symptom checklist cross-cultural adaptation to Brazilian Portuguese language and reliability evaluation. Acta Reumatol Port 2007;4:341-4.
9. Grootscholten C, Snoek FJ, Bijl M, van Houwelingen HC, Derksen RH, Berden JH. Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/methylprednisolone in a randomized controlled trial. J Rheumatol 2007;8:1699-707.
10. Robinson D Jr, Aguilar D, Schoenwetter M, Dubois R, Russak S, Ramsey-Goldman R, et al. Impact of systemic lupus erythematosus on health, family, and work: the patient perspective. Arthritis Care Res (Hoboken) 2010;2:266-73.
11. Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, et al. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol 2009;6:1209-16.
12. Kiani AN, Petri M. Quality-of-life measurements versus disease activity in systemic lupus erythematosus. Curr Rheumatol Rep 2010;4:250-8.
13. Yee CS, McElhone K, Teh LS, Gordon C. Assessment of disease activity and quality of life in systemic lupus erythematosus -new aspects. Best Pract Res Clin Rheumatol 2009;4:457-67.
14. McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus 2006;10:633-43.
15. Wolfe F, Michaud K, Li T, Katz RS. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol 2010;2:296-304.
16. Da Costa D, Dobkin PL, Fitzcharles MA, Fortin PR, Beaulieu A, Zummer M, et al. Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol 2000;2:365-72.
17. Gilboe IM, Kvien TK, Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol 1999;8:1694-700.
18. Almehed K, Carlsten H, Forsblad-d'Elia H. Health-related quality of life in systemic lupus erythematosus and its association with disease and work disability. Scand J Rheumatol 2010;1:58-62.
19. Mok CC, Ho LY, Cheung MY, Yu KL, To CH. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Scand J Rheumatol 2009;2:121-7.
20. Bauernfeind B, Aringer M, Prodinger B, Kirchberger I, Machold K, Smolen J, et al. Identification of relevant concepts of functioning in daily life in people with systemic lupus erythematosus: a patient Delphi exercise. Arthritis Rheum 2009;1:21-8.
21. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;11:1271-7.
22. Persson LO, Karlsson J, Bengtsson C, Steen B, Sullivan M. The Swedish SF-36 Health Survey II. Evaluation of clinical validity: results from population studies of elderly and women in Gothenborg. J Clin Epidemiol 1998;11:1095-103.
23. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;2:69-77.
24. Lisspers J, Nygren A, Soderman E. Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample. Acta Psychiatr Scand 1997;4:281-6.
25. Liang MH, Socher SA, Roberts WN, Esdaile JM. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988;7:817-25.
26. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;9:1107-18.
27. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;6:630-40.
28. Chang E, Abrahamowicz M, Ferland D, Fortin PR. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians. J Clin Epidemiol 2002;5:488-97.
29. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;3:363-9.
30. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;5:809-13.
31. Tishelman C, Lovgren M, Broberger E, Hamberg K, Sprangers MA. Are the most distressing concerns of patients with inoperable lung cancer adequately assessed? A mixed-methods analysis. J Clin Oncol 2010;11:1942-9.
32. Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. Br Med J 1992;6840:1491-4.
33. Gunnarsson I, van Vollenhoven RF. Biologicals for the treatment of systemic lupus erythematosus? Ann Med. Published online 15 April 2011. doi:10.3109/07853890.2011.561362.
34. Kalunian K, Joan TM. New directions in the treatment of systemic lupus erythematosus. Curr Med Res Opin 2009;6:1501-14.
35. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology. Lupus 2000;5: 322-7.
36. Thumboo J, Strand V. Health-related quality of life in patients with systemic lupus erythematosus: an update. Ann Acad Med Singapore 2007;2:115-22.
37. Leong KP, Kong KO, Thong BY, Koh ET, Lian TY, Teh CL, et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology (Oxford) 2005;10:1267-76.
38. McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, et al. Development and validation of a disease-specific healthrelated quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 2007;6:972-9.
39. Kwoh CK, Ibrahim SA. Rheumatology patient and physician concordance with respect to important health and symptom status outcomes. Arthritis Rheum 2001;4:372-7.
40. Leong KP, Chong EY, Kong KO, Chan SP, Thong BY, Lian TY, et al. Discordant assessment of lupus activity between patients and their physicians: the Singapore experience. Lupus 2010;1:100-6.
41. Yen JC, Abrahamowicz M, Dobkin PL, Clarke AE, Battista RN, Fortin PR. Determinants of discordance between patients and physicians in their assessment of lupus disease activity. J Rheumatol 2003;9:1967-76.
42. Neville C, Clarke AE, Joseph L, Belisle P, Ferland D, Fortin PR. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol 2000;3:675-9.